Jacques Galipeau: Cellular pharmaceuticals meet the Wisconsin Idea

Traditionally, drug development arises from a university discovery for which a pharmaceutical company acquires the rights and thereafter navigates the path to market approval. This process of shepherding a therapeutic discovery to become a U.S. Food and Drug Administration (FDA)-approved drug costs hundreds of millions of dollars.

Read the full article at: https://www.med.wisc.edu/quarterly/volume-21-number-1/cellular-pharmaceuticals-meet-the-wisconsin-idea/